Axcelis Announces Participation in SEMICON China 2024
Axcelis Announces Participation in SEMICON China 2024
PR Newswire
BEVERLY, Mass., March 14, 2024
BEVERLY, Mass., March 14, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will sponsor the Power and Compound Semiconductor Forum at SEMICON China 2024. The event is being held March 20-22, 2024, at the Shanghai New International Expo Center.
During the Forum, Axcelis will host the following technical seminar:
Ion Implantation and Applications for Power Devices
Presented by Causon Ko-Chuan Jen, Ph.D, SVP, Technical Marketing
March 21, 2024, 11:35 a.m.-12:00 p.m.
Pudong Ballroom 1, Kerry Hotel Pudong, Shanghai
https://www.semiconchina.org/en/1915
President and CEO of Axcelis Technologies Russell Low, said, "We're excited to be a part of SEMICON China, one of the most important technology forums in the Asia Pacific region. China continues to be a very important market for Axcelis, especially in the power device segment, and we look forward to providing our innovative ion implant technology to chipmakers in China."
About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
CONTACTS:
Maureen Hart (editorial/media) 978.787.4266
Doug Lawson (investor relations) 978.787.9552
View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-participation-in-semicon-china-2024-302088797.html
SOURCE Axcelis Technologies, Inc.
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track